In Silico Identification of Potential Natural Inhibitors of Dengue Virus-2 (DENV-2) NS2B–NS3 Protease
Background: Artificial Intelligence-driven drug discovery has recently made significant advances. Still, no Food and Drug Administration (FDA) approved antiviral drug is available for dengue treatment. The dengue virus NS2B–NS3 protease plays a critical role in viral replication and represents a promising therapeutic t...